TELA Bio (TELA) Current Taxes (2024 - 2026)
TELA Bio's quarterly Current Taxes came in at $796000.0 in Q1 2026, up 9.79% quarter-over-quarter from $725000.0 in Q4 2025.
TELA Bio has reported Current Taxes for 3 years, with the latest figure at $796000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes changed N/A year-over-year to $796000.0; the trailing twelve-month figure through Mar 2026 stood at $796000.0 (changed N/A YoY), and the FY2025 full-year result was $725000.0, up 52.31% from the prior year.
- Current Taxes for Q1 2026 stood at $796000.0, up from $725000.0 in the prior quarter.
- The five-year high for Current Taxes was $796000.0 in Q1 2026, with the low at $476000.0 in Q4 2024.
- Average Current Taxes over 3 years is $665666.7, with a median of $725000.0 recorded in 2025.
- Peak annual rise in Current Taxes reached 52.31% in 2025, while the deepest fall reached 52.31% in 2025.
- Tracing TELA's Current Taxes over 3 years: stood at $476000.0 in 2024, then jumped by 52.31% to $725000.0 in 2025, then grew by 9.79% to $796000.0 in 2026.
- The last three Current Taxes figures came in at $796000.0 (Q1 2026), $725000.0 (Q4 2025), and $476000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 598.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 476.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 650.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 231.81 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 796,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 796,000.00 |
| Dec 31, 2025 | 725,000.00 |
| Dec 31, 2024 | 476,000.00 |